InvestorsHub Logo
Followers 0
Posts 1411
Boards Moderated 0
Alias Born 01/12/2017

Re: None

Saturday, 02/20/2021 7:01:25 AM

Saturday, February 20, 2021 7:01:25 AM

Post# of 4159


On Theralase's website there is a drug pipeline graphic (https://theralase.com/anti-cancer-therapy/pipeline/) displaying the following information (which I've failed to grab and post here in a nice way). It really is quite amazing and promising, what they've got going on:


Discovery / Preclinical / Phase I / Phase II / Phase III

TLD-1433 (INTRAVESICAL PHOTODYNAMIC THERAPY PLATFORM TECHNOLOGY) - NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Pivotal Phase II Clinical Study

RUTHERRIN ® (ENHANCED RADIATION THERAPY PLATFORM TECHNOLOGY OR TECHNOLOGY FOR INNOVATION IN RADIATION ONCOLOGY) – GLIOBLASTOMA MULTIFORME (GBM)
Late Preclinical Stage

RUTHERRIN ® (ENHANCED RADIATION THERAPY PLATFORM TECHNOLOGY OR TECHNOLOGY FOR INNOVATION IN RADIATION ONCOLOGY) – NON-SMALL CELLS LUNG CANCER (NSCLC)
Late Preclinical Stage

RUVACARE(V)® (ANTI-PATHOGEN PLATFORM TECHNOLOGY)- SARS - COV-2 - COVID-19
Preclinical Stage